Your browser doesn't support javascript.
loading
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.
Bonilla, Hector; Peluso, Michael J; Rodgers, Kathleen; Aberg, Judith A; Patterson, Thomas F; Tamburro, Robert; Baizer, Lawrence; Goldman, Jason D; Rouphael, Nadine; Deitchman, Amelia; Fine, Jeffrey; Fontelo, Paul; Kim, Arthur Y; Shaw, Gwendolyn; Stratford, Jeran; Ceger, Patricia; Costantine, Maged M; Fisher, Liza; O'Brien, Lisa; Maughan, Christine; Quigley, John G; Gabbay, Vilma; Mohandas, Sindhu; Williams, David; McComsey, Grace A.
Afiliação
  • Bonilla H; Department of Medicine and Infectious Diseases, Stanford University, Palo Alto, CA, United States.
  • Peluso MJ; Department of Medicine and Infectious Diseases, University of California, San Francisco, San Francisco, CA, United States.
  • Rodgers K; Center for Innovations in Brain Science, University of Arizona, Tucson, AZ, United States.
  • Aberg JA; Department of Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai, Chief, Division of Infectious Disease, New York, NY, United States.
  • Patterson TF; Department of Medicine, Infectious Diseases, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
  • Tamburro R; Division of Intramural Research, National Institute of Health, Bethesda, MD, United States.
  • Baizer L; National Heart Lung and Blood Institute, Division of Lung Diseases, National Institutes of Health, Bethesda, MD, United States.
  • Goldman JD; Department of Medicine, Organ Transplant and Liver Center, Swedish Medical Center, Seattle, WA, United States.
  • Rouphael N; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, United States.
  • Deitchman A; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, United States.
  • Fine J; Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, United States.
  • Fontelo P; Department of Rehabilitation Medicine at New York University (NYU) Grossman School of Medicine, Physical Medicine and Rehabilitation Service, New York University (NYU), New York University Medical Center, New York, NY, United States.
  • Kim AY; Applied Clinical Informatics Branch, National Library of Medicine, National Institutes of Health, Bethesda, MD, United States.
  • Shaw G; Department of Medicine at Harvard Medical School, Division of Infectious Disease, Boston, MA, United States.
  • Stratford J; Research Triangle Institute (RTI), International, Durham, NC, United States.
  • Ceger P; Research Triangle Institute (RTI), International, Durham, NC, United States.
  • Costantine MM; Research Triangle Institute (RTI), International, Durham, NC, United States.
  • Fisher L; Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, United States.
  • O'Brien L; Long COVID Families, Houston, TX, United States.
  • Maughan C; Utah Covid-19 Long Haulers, Salt Lake City, UT, United States.
  • Quigley JG; Utah Covid-19 Long Haulers, Salt Lake City, UT, United States.
  • Gabbay V; Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
  • Mohandas S; Department of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
  • Williams D; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
  • McComsey GA; Department of Medicine, University of Michigan, Ann Arbor, MI, United States.
Front Immunol ; 14: 1129459, 2023.
Article em En | MEDLINE | ID: mdl-36969241

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Viroses / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Viroses / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos